What question did this study set out to answer?

To evaluate one-year outcomes of transcatheter aortic valve implantation (TAVI) as a treatment for severe aortic stenosis in high-risk patients.

October 1, 2013Journal of the Chinese Medical Association

One-year results of transcatheter aortic valve implantation as an alternative treatment for severe aortic stenosis in high-risk patients

View Full Paper

Ask AI

Bookmark

Population

10 high-risk patients with severe aortic stenosis referred for aortic valve replacement, average age 81.5…

Design

Case_series

Follow-up

1 year

Authors

YYYu-Ting YuanGuangzhou Academy of Fine Arts YCYing‐Hwa ChenNational Yang Ming Chiao Tung University PCPo‐Lin ChenNational Yang Ming Chiao Tung University

Discussion

Member takes

Implication

Supports TAVI feasibility in small high-risk aortic stenosis cohort; hypothesis-generating and should not change practice without larger trials.

Key Points

To evaluate one-year outcomes of transcatheter aortic valve implantation (TAVI) as a treatment for severe aortic stenosis in high-risk patients.
Ten high-risk patients with severe aortic stenosis were referred for transcatheter aortic valve implantation.
Patients were divided into two groups based on the approach: six transapical and four transfemoral.
Data on patient demographics, EuroSCORE, aortic parameters, and complications were collected and analyzed.
Surgical technical success achieved 100%.
The mean aortic valve area increased by 251% and the mean pressure gradient decreased by 80% at 3 months follow-up.
The one-year mortality rate was 20%, with a 30-day mortality rate of 10%.

Structured PICO

Population

10 high-risk patients with severe aortic stenosis referred for aortic valve replacement, average age 81.5 years, mean logistic EuroSCORE 28.3 ± 7.9%.

Intervention

Transcatheter aortic valve implantation (TAVI) via transapical (n=6) or transfemoral (n=4) approach.

Outcome

Immediate, 1-month, 3-month, and 1-year clinical and echocardiographic outcomes (including mortality, complications, aortic valve area, and mean pressure gradient).hard clinical

In a small series of high-risk patients with severe aortic stenosis, TAVI demonstrated 100% technical success with a 1-year all-cause mortality of 20% and significant hemodynamic improvements.

Cite This Study

Yuan et al. (2013) studied this question.

synapsesocial.com/papers/6a0827caab15ea61dee8b1ff https://doi.org/10.1016/j.jcma.2013.08.007

Topics

Echocardiography

View Full Paper

Ask AI

Bookmark

Implication

Supports TAVI feasibility in small high-risk aortic stenosis cohort; hypothesis-generating and should not change practice without larger trials.

One-year results of transcatheter aortic valve implantation as an alternative treatment for severe aortic stenosis in high-risk patients

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

One-year results of transcatheter aortic valve implantation as an alternative treatment for severe aortic stenosis in high-risk patients

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider